Binding of a SART3 tumor-rejection antigen to a pre-mRNA splicing factor RNPS1: A possible regulation of splicing by a complex formation

International Journal of Cancer

Volumn 93, Issue 5, 2001, Pages 623-628

  Harada, Kenji ^b   Yamada, Akira ^b   Yang, Damu ^a   Itoh, Kyogo ^b   Shichijo, Shigeki ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KURUME UNIVERSITY   (Japan)

Author keywords

2 Hybrid; CTL; Immunoprecipitation; RNA binding protein; Tumor rejection antigens

Indexed keywords

CALCITONIN; DIHYDROFOLATE REDUCTASE; MESSENGER RNA; MESSENGER RNA PRECURSOR; PROTEIN RNPS1; PROTEIN SART3; RNA BINDING PROTEIN; SERINE; SQUAMOUS CELL CARCINOMA ANTIGEN; TUMOR REJECTION ANTIGEN; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; RNA SPLICING; TUMOR REJECTION;

ANTIGENS, NEOPLASM; DNA-BINDING PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PRECIPITIN TESTS; RIBONUCLEOPROTEINS; RNA PRECURSORS; RNA SPLICE SITES; RNA SPLICING; RNA, MESSENGER; RNA-BINDING PROTEINS; SUBCELLULAR FRACTIONS; T-LYMPHOCYTES, CYTOTOXIC; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0035452417     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1391     Document Type: Article

References (41)

1. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma
2. Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
3. Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells
4. Identification of a gene coding for a protein possessing shared tumor epitopes capable of inducing HLA-A24-restricted cytotoxic T lymphocytes in cancer patients
5. RNA editing in Drosophila 4f-rnp gene nuclear transcripts by multiple A-to-G conversions
6. Mammalian Ras interacts directly with the serine/threonine kinase Raf
7. A new protein containing an SH2 domain that inhibits JAK kinases
8. Analysis of the RNA-recognition motif and RS and RGG domains: Conservation in metazoan pre-mRNA splicing factors
9. nrb)
10. Identification and characterization of a novel human RNA-binding protein
11. The Clk/Sty protein kinase phosphorylates SR splicing factors and regulates their intranuclear distribution
12. Specific interactions between proteins implicated in splice site selection and regulated alternative splicing
13. Protein-protein interactions and 5′-splice-site recognition in mammalian mRNA precursors
14. A gene encoding antigenic peptides of human squamous cell carcinoma recognized by cytotoxic T lymphocytes
15. Mouse homologue of the human SART3 gene encoding tumor-rejection antigen
16. Control of 3′ splice site choice in vivo by ASF/SF2 and hnRNP A1
17. Purification and characterization of human RNPS1: A general activator of pre-mRNA splicing
18. cdc2-related PITSLRE protein kinase in vivo
19. Sequence of a complete murine cDNA reflecting an S phase-prevalent transcript encoding a protein with two types of nucleic acid binding motifs
20. A Y chromosome gene family with RNA-binding protein homology: Candidates for the azoospermia factor AZF controlling human spermatogenesis
21. The Rb97D gene encodes a potential RNA-binding protein required for spermatogenesis in Drosophila
22. Drosophila sex determination: A cascade of regulated splicing
23. Initial organization of the Drosophila dorsoventral axis depends on an RNA-binding protein encoded by the squid gene
24. SR protein kinases: The splice of life
25. Identification of SART3-derived peptides capable of inducing HLA-A2-restricted and tumor-specific CTLs in cancer patients with different HLA-A2 subtypes
26. Nuclear ultrastructures associated with the RNA synthesis and processing
27. Splice site selection, rate of splicing, and alternative splicing on nascent transcripts
28. Intron-dependent recruitment of pre-mRNA splicing factors to sites of transcription
29. The dynamics of a pre-mRNA splicing factor in living cells
30. Identification of proliferation-sensitive human proteins amongst components of the 40 S hnRNP particles: Identity of hnRNP core proteins in the HeLa protein catalogue
31. Modulation of hnRNP A1 protein gene expression by epidermal growth factor in Rat-1 cells
32. Alternative splicing of the p53 tumor suppressor gene in the Molt-4 T-lymphoblastic leukemia cell line
33. Cyclin D1 (PRAD1) alternative transcript b: Full length cDNA cloning and expression in breast cancers
34. Estrogen receptor variant messenger RNA lacking exon 4 in estrogen-responsive human breast cancer cell lines
35. A truncated intracellular HER2/neu receptor produced by alternative RNA processing affects growth of human carcinoma cells
36. Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast
37. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation
38. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression
39. Coordinate oncodevelopmental modulation of alternative splicing of fibronectin pre-mRNA at ED-A, ED-B, and CS1 regions in human liver tumors
40. Qualitative and quantitative changes of human tenescin expression in transformed lung fibroblast and lung tumor tissues: Comparison with fibronectin
41. Stage-specific changes in SR splicing factors and alternate splicing in mammary tumorigenesis